Provided by Tiger Trade Technology Pte. Ltd.

ZyVersa Therapeutics, Inc.

0.2000
+0.040025.00%
Volume:42.15K
Turnover:8.31K
Market Cap:1.62M
PE:-0.04
High:0.2000
Open:0.1600
Low:0.1600
Close:0.1600
52wk High:1.94
52wk Low:0.1100
Shares:8.10M
Float Shares:7.67M
Volume Ratio:0.57
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6800
EPS(LYR):-8.4803
ROE:-112.65%
ROA:-46.30%
PB:-0.14
PE(LYR):-0.02

Loading ...

Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 16, 2025

Major Issues Report

Form 8-K - Current report
Oct 06, 2025

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Sep 18, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Correspondence

Form CORRESP - Correspondence
Aug 02, 2025

Correspondence

Form CORRESP - Correspondence
Aug 01, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 28, 2025

Major Issues Report

Form 8-K - Current report
Jul 18, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 16, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Major Issues Report

Form 8-K - Current report
Jul 02, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 25, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Major Issues Report

Form 8-K - Current report
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 09, 2025

Correspondence

Form CORRESP - Correspondence